Skip to content
stoqly

Veeco Instruments Inc

VECO Nasdaq Special Industry Machinery, Nec Financials FY2016–FY2025

Revenue Total sales reported in the income statement.
$664M
7.4% vs prior year
Operating margin Operating income as a share of revenue.
5.4%
4.0 pts
Net income Profit after all expenses, interest and tax.
$35.4M
52.0%
Free cash flow Cash from operations minus capital spending.
$53.3M
16.6%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
4.4%
5.1 pts
Market cap Last close times the latest diluted share count, so it is approximate.
β€”
P/E Last close divided by diluted earnings per share over the last four quarters.
β€”
On $0.36 EPS (TTM)

What Veeco Instruments Inc does

No business description yet.

Legal name
VEECO INSTRUMENTS INC
Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Feb 25, 2026
Accession Β· CIK
0001104659-26-019711
0000103145

Revenue and margins

Veeco Instruments Inc had $664M of revenue in fiscal 2025, down 7.4% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $53.3M in fiscal 2025, 8.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Veeco Instruments Inc returned β€” to shareholders in fiscal 2025. The diluted share count fell 1.6%.

Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Veeco Instruments Inc can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $224M$302M$305M$344M$390M
Debt incl. finance leases $229M$275M$275M$276M$226M
Net debt / EBITDA 0.1xβˆ’0.3xβˆ’0.3xβˆ’0.7xβˆ’2.9x
Debt / equity 0.5x0.5x0.4x0.4x0.3x
Interest coverage 2.0x5.2x5.9x6.1x3.9x
Current ratio 2.9x2.6x3.2x4.0x4.7x
Quick ratio 2.0x1.8x2.1x2.7x3.2x
Total assets $899M$1.1B$1.2B$1.3B$1.3B
Total liabilities $461M$550M$557M$481M$440M
Shareholders' equity $438M$578M$672M$771M$886M
Net debt (βˆ’ = net cash) $5.5Mβˆ’$27.8Mβˆ’$30.5Mβˆ’$68.1Mβˆ’$164M

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Net income is positive βœ• βœ• βœ• βœ• βœ• βœ“ βœ“ βœ• βœ“ βœ“
Cash from operations is positive βœ• βœ“ βœ• βœ• βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Return on assets rose β€” βœ“ βœ• βœ“ βœ“ βœ“ βœ“ βœ• βœ“ βœ•
Cash from operations exceeds net income βœ“ βœ“ βœ“ βœ“ βœ“ βœ“ βœ• βœ“ βœ• βœ“
Debt fell relative to assets β€” βœ• βœ• βœ• βœ“ βœ“ βœ“ βœ“ βœ“ βœ“
Current ratio rose β€” βœ• βœ“ βœ“ βœ• βœ• βœ• βœ“ βœ“ βœ“
Share count didn't rise β€” βœ• βœ• βœ• βœ• βœ• βœ• βœ“ βœ• βœ“
Gross margin rose β€” βœ• βœ• βœ“ βœ“ βœ• βœ• βœ“ βœ• βœ•
Revenue rose relative to assets β€” βœ• βœ“ βœ• βœ• βœ“ βœ• βœ• βœ“ βœ•
F-score β€” / 33 / 93 / 94 / 95 / 96 / 94 / 96 / 96 / 96 / 9
Accruals ratio βˆ’12.9%βˆ’8.1%βˆ’32.3%βˆ’8.3%βˆ’6.0%βˆ’4.6%5.8%βˆ’7.8%0.8%βˆ’2.6%
Altman Z'' 5.162.53βˆ’1.730.641.691.582.402.853.854.55

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $332M $485M $542M $419M $454M $583M $646M $666M $717M $664M
Gross profit $133M $176M $194M $158M $194M $242M $263M $285M $304M $265M
Research and development $81.0M $82.0M $97.8M $90.6M $79.0M $88.7M $104M $113M $125M $120M
Operating income βˆ’$120M βˆ’$71.9M βˆ’$416M βˆ’$39.6M $22.6M $56.7M $60.3M $69.9M $67.0M $35.7M
Interest expense $0.2M $19.5M $21.5M $22.1M $24.7M $28.4M $11.5M $11.8M $11.0M $9.1M
Pretax income βˆ’$119M βˆ’$89.0M βˆ’$434M βˆ’$78.0M βˆ’$8.5M $25.7M $51.0M βˆ’$28.3M $68.8M $39.4M
Income tax $2.8M βˆ’$37.6M βˆ’$26.7M $0.8M βˆ’$0.1M βˆ’$0.4M βˆ’$116M $2.0M βˆ’$4.9M $4.0M
Net income βˆ’$122M βˆ’$51.4M βˆ’$407M βˆ’$78.7M βˆ’$8.4M $26.0M $167M βˆ’$30.4M $73.7M $35.4M
Net income to common βˆ’$122M βˆ’$51.4M βˆ’$407M βˆ’$78.7M βˆ’$8.4M $26.0M $167M βˆ’$30.4M $73.7M $35.4M
Diluted EPS βˆ’$3.10 βˆ’$1.16 βˆ’$8.63 βˆ’$1.66 βˆ’$0.17 $0.49 $2.71 βˆ’$0.56 $1.23 $0.59
Diluted shares 0.04B 0.04B 0.05B 0.05B 0.05B 0.05B 0.07B 0.05B 0.06B 0.06B
Cash flow
Cash from operations βˆ’$23.8M $35.0M βˆ’$37.7M βˆ’$7.4M $43.0M $67.7M $108M $61.7M $63.8M $69.5M
Capital expenditure $11.5M $24.3M $12.7M $10.9M $6.8M $40.6M $24.6M $27.9M $18.1M $16.2M
Free cash flow βˆ’$35.3M $10.7M βˆ’$50.4M βˆ’$18.3M $36.2M $27.1M $83.9M $33.7M $45.7M $53.3M
Depreciation and amortization $32.7M $50.1M $50.0M $34.4M $30.7M $26.1M $25.6M $25.0M $25.1M $20.0M
Stock-based compensation $15.7M $24.4M $16.1M $15.3M $12.7M $15.2M $23.0M $28.6M $35.9M $37.0M
Acquisitions β€” $402M $2.7M β€” β€” β€” β€” $30.4M β€” β€”
Share buybacks $13.3M $2.9M $11.5M β€” β€” β€” β€” β€” β€” β€”
Dividends and buybacks $13.3M $2.9M $11.5M β€” β€” β€” β€” β€” β€” β€”
Balance sheet
Cash and short-term investments $344M $328M $260M $245M $319M $224M $302M $305M $344M $390M
Total debt $1.2M $276M $287M $300M $321M $229M $275M $275M $276M $226M
Current assets $502M $597M $520M $476M $587M $549M $669M $706M $765M $845M
Current liabilities $144M $224M $160M $118M $147M $189M $258M $218M $192M $178M
Inventory $77.1M $120M $156M $133M $146M $171M $207M $238M $247M $275M
Property and equipment, net $60.6M $85.1M $80.3M $75.7M $65.3M $99.7M $107M $118M $114M $109M
Goodwill $115M $307M $184M $182M $182M $182M $182M $215M $215M $215M
Intangible assets $58.4M $370M $85.1M $61.5M $46.2M $33.9M $23.9M $43.9M $8.8M $5.7M
Total assets $759M $1.4B $901M $818M $898M $899M $1.1B $1.2B $1.3B $1.3B
Total liabilities $164M $547M $463M $444M $490M $461M $550M $557M $481M $440M
Shareholders' equity $602M $840M $438M $375M $408M $438M $578M $672M $771M $886M
Margins
Gross margin 40.0% 36.4% 35.7% 37.7% 42.8% 41.5% 40.7% 42.8% 42.4% 40.0%
Operating margin βˆ’36.1% βˆ’14.8% βˆ’76.6% βˆ’9.4% 5.0% 9.7% 9.3% 10.5% 9.3% 5.4%
EBITDA margin βˆ’26.3% βˆ’4.5% βˆ’67.4% βˆ’1.2% 11.7% 14.2% 13.3% 14.2% 12.8% 8.4%
Net margin βˆ’36.7% βˆ’10.6% βˆ’75.1% βˆ’18.8% βˆ’1.8% 4.5% 25.8% βˆ’4.6% 10.3% 5.3%
FCF margin βˆ’10.6% 2.2% βˆ’9.3% βˆ’4.4% 8.0% 4.6% 13.0% 5.1% 6.4% 8.0%
Returns
Return on capital βˆ’36.7% βˆ’7.2% βˆ’70.6% βˆ’7.3% 4.3% 12.8% 11.0% 8.6% 9.5% 4.4%
Return on capital employed βˆ’19.5% βˆ’6.2% βˆ’56.1% βˆ’5.7% 3.0% 8.0% 6.9% 6.9% 6.3% 3.1%
Return on equity βˆ’20.3% βˆ’7.1% βˆ’63.7% βˆ’19.4% βˆ’2.1% 6.2% 32.9% βˆ’4.9% 10.2% 4.3%
Return on assets βˆ’16.1% βˆ’4.8% βˆ’35.6% βˆ’9.2% βˆ’1.0% 2.9% 16.5% βˆ’2.6% 5.9% 2.7%
Return on tangible equity βˆ’28.5% βˆ’31.5% βˆ’241.8% βˆ’60.1% βˆ’4.7% 11.7% 44.9% βˆ’7.3% 13.5% 5.3%
Growth
Revenue growth β€” 45.8% 11.8% βˆ’22.6% 8.3% 28.4% 10.8% 3.1% 7.6% βˆ’7.4%
Net income growth β€” β€” β€” β€” β€” β€” 541.1% βˆ’118.2% β€” βˆ’52.0%
EPS growth β€” β€” β€” β€” β€” β€” 453.1% βˆ’120.7% β€” βˆ’52.0%
FCF growth β€” β€” βˆ’570.0% β€” β€” βˆ’25.2% 209.5% βˆ’59.8% 35.4% 16.6%
Share count change β€” 12.3% 6.7% 0.7% 1.9% 10.9% 22.3% βˆ’18.0% 14.6% βˆ’1.6%
Financial health
Net debt / EBITDA β€” β€” β€” β€” 0.0x 0.1x βˆ’0.3x βˆ’0.3x βˆ’0.7x βˆ’2.9x
Debt / equity 0.0x 0.3x 0.7x 0.8x 0.8x 0.5x 0.5x 0.4x 0.4x 0.3x
Interest coverage βˆ’541.3x βˆ’3.7x βˆ’19.3x βˆ’1.8x 0.9x 2.0x 5.2x 5.9x 6.1x 3.9x
Current ratio 3.5x 2.7x 3.2x 4.0x 4.0x 2.9x 2.6x 3.2x 4.0x 4.7x
Quick ratio 3.0x 2.1x 2.3x 2.9x 3.0x 2.0x 1.8x 2.1x 2.7x 3.2x
Capital allocation
Capex / revenue 3.5% 5.0% 2.3% 2.6% 1.5% 7.0% 3.8% 4.2% 2.5% 2.4%
Stock comp / revenue 4.7% 5.0% 3.0% 3.6% 2.8% 2.6% 3.6% 4.3% 5.0% 5.6%
Payouts / FCF β€” 26.8% β€” β€” β€” β€” β€” β€” β€” β€”
Quality scores
Piotroski F-score β€” 3.0 3.0 4.0 5.0 6.0 4.0 6.0 6.0 6.0
Altman Z'' 5.2 2.5 βˆ’1.7 0.6 1.7 1.6 2.4 2.8 3.8 4.6
Accruals ratio βˆ’12.9% βˆ’8.1% βˆ’32.3% βˆ’8.3% βˆ’6.0% βˆ’4.6% 5.8% βˆ’7.8% 0.8% βˆ’2.6%

Source: SEC EDGAR XBRL filings (CIK 0000103145). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β€” not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move Β· ↡ to open